Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-22-053312

Director sold 7,324 shares at $16.16 ($118,349)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
SCHIFF ANDREW N Director 2022-10-07 Sale −7,324 $16.16 $118,349 581,592 I
Open-market sales · 7,324 sh · avg $16.16 · $118,349
Loading xslF345X03/doc4.xml…